CTSS and rheumatoid arthritis: Finally, to corroborate the role of cathepsin S in the degradation of endostatin in vivo, we measured it in serum samples from RA patients and from the healthy controls and observed a reduction in cathepsin S concentrations and activity after 6 months of tofacitinib treatment relative to the samples before treatment (Figure 9A,B).